4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-22-005296
Options or other derivatives
- Director acquired 31,293 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Babler Martin Director | 2022-06-17 | Grant or award · Director Stock Option (Right to Buy) | +31,293 | 31,293 | D | ||
Loading xslF345X03/primarydocument.xml…